Companies
RNS
Signals
Macro
Research
Indices
Ticker TV
Events
Commodities
Currencies

· Data products

Developer Portal News Services

Overview Central banks RNS Book a demo

/Equities/XLON/LLAI

DelistedThis company is no longer listed on the London Stock Exchange.

Lunglife AI, INC

Overview Financials RNS Directors

/Equities/XLON/LLAI

DelistedThis company is no longer listed on the London Stock Exchange.

Lunglife AI, INC

Overview Financials RNS Directors

Lunglife AI, INC (LLAI) — Delisted · Historical data & RNS archive | Ticker

/Equities/XLON/LLAI

DelistedThis company is no longer listed on the London Stock Exchange.

Lunglife AI, INC

Overview Financials RNS Directors

/Equities/XLON/LLAI

DelistedThis company is no longer listed on the London Stock Exchange.

Lunglife AI, INC

Overview Financials RNS Directors

Financial Health

Principal risks: 1

Recent RNS announcements

No recent announcements

Annual Reports

1 Jan 2023	Annual Report for the year ended 31 December 2022
1 Jan 2022	Annual Report for the year ended 31 December 2021

Directors (6)

Dr Paul PaganoExecutive Director

–

David AndersonExecutive Director

–

Roy DavisNon-Executive Director

–

Andrew BotelerNon-Executive Director

–

Sara BarringtonNon-Executive Director

–

Company details

LungLife AI is an AI-based diagnostic firm that specializes in the timely detection of lung cancer through a basic blood test.

Industry: Health Care
Sector: Health Care
LEI: 549300VBVDIF0Y3OVI38
Region: North America
Admission date: 8 Jul 2021
Website: lunglifeai.com
X: @LungLifeAI

Shares details

Shares in issue: —

Dividends

Financial Health

Principal risks: 1

Recent RNS announcements

No recent announcements

Annual Reports

1 Jan 2023	Annual Report for the year ended 31 December 2022
1 Jan 2022	Annual Report for the year ended 31 December 2021

Directors (6)

Dr Paul PaganoExecutive Director

–

David AndersonExecutive Director

–

Roy DavisNon-Executive Director

–

Andrew BotelerNon-Executive Director

–

Sara BarringtonNon-Executive Director

–

Company details

LungLife AI is an AI-based diagnostic firm that specializes in the timely detection of lung cancer through a basic blood test.

Industry: Health Care
Sector: Health Care
LEI: 549300VBVDIF0Y3OVI38
Region: North America
Admission date: 8 Jul 2021
Website: lunglifeai.com
X: @LungLifeAI

Shares details

Shares in issue: —

Dividends

Latest year: FY22
Dividend: No dividend declared

Instrument details

ISIN: USU5500L1045
Exchange: —
Market: Aim

Latest year: FY22
Dividend: No dividend declared

Instrument details

ISIN: USU5500L1045
Exchange: —
Market: Aim